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In vertebrates, endothelial cells (ECs) form blood
vessels in every tissue. Here, we investigated vas-
cular lumen formation in the developing aorta, the
first and largest arterial blood vessel in all verte-
brates. Comprehensive imaging, pharmacological
manipulation, and genetic approaches reveal that,
in mouse embryos, the aortic lumen develops extra-
cellularly between adjacent ECs. We show that ECs
adhere to each other, and that CD34-sialomucins,
Moesin, F-actin, and non-muscle Myosin II localize
at the endothelial cell-cell contact to define the
luminal cell surface. Resultant changes in EC shape
lead to lumen formation. Importantly, VE-Cadherin
and VEGF-A act at different steps. VE-Cadherin is
required for localizing CD34-sialomucins to the
endothelial cell-cell contact, a prerequisite to Moesin
and F-actin recruitment. In contrast, VEGF-A is
required for F-actin-nm-Myosin II interactions and
EC shape change. Based on these data, we propose
a molecular mechanism of in vivo vascular lumen
formation in developing blood vessels.
INTRODUCTION
Blood vessels are multicellular tubes, essential for the transport
of fluids, gases, and nutrients in all vertebrates. They are com-
posed of endothelial cells (ECs) that form an interface between
the circulating blood and the surrounding tissues. During blood
vessel formation, ECs first assemble into multicellular cords
before forming a vascular lumen (Czirok et al., 2008; Kamei
et al., 2006). Previous findings suggest that, following cord forma-
tion, ECs form a lumen via coalescence of intracellular vacuoles
that persist in ECs for several hours (Davis and Camarillo, 1996;
Folkman and Haudenschild, 1980; Kamei et al., 2006; Sabin,
1920). Based on this model, large intracellular vacuoles give
rise to so-called seamless blood vessels, which have no junctions
in transverse section (Kamei et al., 2006). However, most blood
vessels are not seamless, as they display auto- and intercellularDevelopjunctions in transverse sections, indicating an alternative mecha-
nism of vascular lumen formation (Blum et al., 2008; Drake and
Fleming, 2000; Jin et al., 2005; Parker et al., 2004).
Here, we investigate vascular lumen formation in the devel-
oping aorta, which is the first and largest arterial blood vessel
in all mammals (Drake and Fleming, 2000; Sato et al., 2008). In
mice, similar to humans, the aorta develops from two lateral
EC cords, called dorsal aortae, that fuse at later stages of devel-
opment (Drake and Fleming, 2000; Lammert et al., 2001). Here,
we show that lumen formation in the dorsal aortae within the
developing mouse embryo is a temporally and spatially defined
process. Analyzing the transition from an EC cord to a vascular
tube via electron microscopy (EM) and confocal light micros-
copy, as well as via various pharmacological and genetic manip-
ulation experiments, allowed us to propose a molecular mecha-
nism of how the aortic lumen develops in vivo.
RESULTS
Aortic Lumen Formation Initiates between the 1S and 3S
Stages of Mouse Embryonic Development
To determine the timing and positioning of the transition from an
EC cord to a vascular tube, we used single-plane illumination
microscopy (SPIM) and confocal light microscopy to image the
developing dorsal aortae in whole mouse embryos and in trans-
verse sections, respectively (Figure 1). At the 1–2 somite (1–2S)
stage of mouse development, on embryonic day (E) 8.0
(Figure 1A), ECs formed clusters (Figures 1B and 1C; see Movie
S1 available online). A few hours later, at the 3–5S stage
(Figure 1D), continuous EC cords were observed (Figure 1E
and Movie S1), most of which had formed a vascular lumen
(asterisk in Figure 1F). By the 6–8S stage on E8.25 (Figure 1G),
the dorsal aortae were enlarged (Figure 1H and Movie S1),
and the process of lumen formation was complete (Figure 1I).
During the next day of mouse development (Figure 1J), a
complex circulatory system developed (Figure 1K and Movie
S1), and the aortic lumen further increased (Figure 1L).
We conclude that lumen formation in the developing dorsal
aortae initiates between the 1S and 3S stages of mouse embry-
onic development, followed by completion and expansion of the
aortic lumen as well as vascular sprouting.mental Cell 17, 505–515, October 20, 2009 ª2009 Elsevier Inc. 505
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Vascular Lumen Formation in the Developing AortaThe Aortic Lumen Develops Extracellularly
To investigate the onset of vascular lumen formation, we per-
formed an ultrastructural EM analysis of transverse sections
through the developing dorsal aortae. At the 1S stage
(Figure 2A), ECs clustered and were connected by junctions at
multiple points (yellow arrowheads in Figures 2A and 2A0). At
the 2S stage (Figure 2B), however, the junctions were located
at lateral positions, leaving adjacent cells separated by a narrow,
slit-like extracellular space (asterisks in Figure 2B0). At the 3–5S
stage (Figure 2C), this extracellular space was increased, form-
ing a vascular lumen larger than 5 mm, the diameter of capillaries,
the smallest functional blood vessels in vertebrates. We refer to
dorsal aortae with a lumen smaller than 5 mm in diameter as
‘‘cords’’ (Figures 2A and 2B), and dorsal aortae with a lumen
larger than 5 mm as ‘‘tubes’’ (Figures 2C and 2D). At the 6–8S
stage (Figure 2D), the aortic lumen was larger than 20 mm in
diameter and the ECs were significantly thinner compared to
the 1–2S stage. We conclude that initiation of lumen formation
in the dorsal aortae is accompanied by relocalization of junc-
tions, formation and increase of extracellular space between
adjacent ECs, and cell shape changes.
Experiments in zebrafish embryos led to the proposal that
vascular lumen formation is driven by the production of large
intracellular vacuoles that remain in ECs for several hours (Kamei
et al., 2006). In contrast, our comprehensive EM analysis of
33 mouse embryos and 230 transverse sections through the
developing dorsal aortae during the short transition from cord
Figure 1. Lumen Formation in the Devel-
oping Aorta Is Initiated Between the 1S
and 3S Stages of Mouse Development
(A, D, G, J) Lateral bright-field images of mouse
embryos at the indicated embryonic stages
(E8.0–E9.25; 1–22S stages).
(B, E, H, K) Three-dimensional, single-plane illumi-
nation microscopy (SPIM) images of mouse
embryos at the indicated stages, stained for EC
marker PECAM-1, and viewed as indicated in
(A, D, G, J). CP, cardiogenic plate; em, embryonic
tissue; ex, extraembryonic tissue; x, notochord;
YS, yolk sac. See Movie S1.
(C, F, I, L) Confocal light microscopic images of
transverse sections indicated in (A), (D), (G), and
(J) through the ventral part of staged mouse
embryos stained for PECAM-1. En, endoderm;
Mes, mesenchyme; NE, neuroepithelium; x, noto-
chord. Endothelial cell (EC) cords are indicated
with arrowheads; aortic lumens are labeled with
asterisks. Scale bars, 250 mm (A, B, D, E, G, H),
50 mm (C, F, I, L), and 500 mm (J, K).
to tube (E8.0–E8.25) did not reveal any
intracellular vacuoles with a diameter
larger than 0.5 mm (Figure 2E). Although
vacuole-like structures were occasionally
observed in transverse sections (see
small asterisk in Figure S1B), the com-
plete series of sections through the
developing dorsal aortae revealed that
these structures were plasma membrane
invaginations rather than intracellular vacuoles (Figures S1A and
S1C–S1L).
In line with the hypothesis that targeting of exocytotic vesicles
to the future luminal plasma membrane is important for creating
a multicellular lumen, we observed small vesicles, constituting
less than 1% of the luminal area, within ECs during the transition
from cord to a vascular tube (Figures 2F and 2G). Moreover,
consistent with the observation that most developing blood
vessels are initially permeable, we showed that the developing
aortic lumen is continuous with the surrounding extravascular in-
terstitium due to the presence of paracellular openings (arrow-
head in Figure 2H).
Taken together, these data suggest that the aortic lumen
develops extracellularly at the cell-cell contact between adjacent
ECs.
CD34-Sialomucins, Moesin, F-Actin, and Non-Muscle
Myosin II Localize to the Endothelial Cell-Cell Contact
at the Onset of Aortic Lumen Formation
Formation of the apical plasma membrane is thought to be a
key step during lumen formation in epithelial cells (reviewed by
Bryant and Mostov, 2008; Lubarsky and Krasnow, 2003). In
these cells, Podocalyxin (PODXL or gp135) is commonly used
as an apical cell surface marker (Meder et al., 2005). It belongs
to the family of functionally redundant CD34-sialomucins
(reviewed be Nielsen and McNagny, 2008), all of which are
expressed in ECs.506 Developmental Cell 17, 505–515, October 20, 2009 ª2009 Elsevier Inc.
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Vascular Lumen Formation in the Developing AortaFigure 2. Extracellular Vascular Lumen Formation in the Developing Aorta
(A–D) Electron micrographs of ultrathin transverse sections through aortic endothelial cells (ECs) at the indicated stages of mouse development. En, endoderm;
Mes, mesenchyme. Scale bars, 5 mm. (A) 1S stage: adjacent ECs joined by junctions (yellow arrowheads). (A0) Higher magnification of the depicted area in (A).
(B) 2S stage: adjacent ECs with junctions (yellow arrowheads) at lateral positions separated by a slit-like extracellular space. (B0) Higher magnification of the
depicted area in (B). (C) 3-5S stage: ECs are separated by an increased extracellular space (asterisk). (D) 6–8S stage: thin ECs surround a vascular lumen.
(E) Quantification of intracellular vacuoles larger than 0.5 mm. Numbers of embryos and aortic sections analyzed by electron microscopy (EM) are indicated.
(F) Quantification of the diameter of intracellular vesicles based on EM images of transverse sections throughaortic ECs present in EC cords andvascular tubes; n = 50
dorsal aortae present as either cord or tube of nR 3 embryos.
(G) Quantification of the area of intracellular vesicles in cords and the extracellular luminal area in vascular tubes based on EM images of transverse sections through
aortic ECs; n = 50 dorsal aortae present as either cord or tube of nR 3 embryos. Values are means ± SEM.
(H) Electron micrograph of an ultrathin transverse section through the developing aorta (8Sstage) shows that the vascular lumen (asterisk) is continuous with the extra-
vascular interstitium through a paracellular opening (arrowhead). Scale bar, 5 mm.In aortic ECs, we found two CD34-sialomucins (CD34 and
PODXL) present at the early onset of vascular lumen formation
(Figures 3A–3F). Immunostaining of transverse sections through
the developing dorsal aortae revealed a cytoplasmic vesicular
distribution of CD34 and PODXL at the 1S stage (Figures 3A
and 3B). In contrast, at the 2S stage, both CD34-sialomucins
were predominantly localized at the cell-cell contact of adjacent
ECs, thus defining the endothelial cell-cell contact as the apical
site where the future aortic lumen develops (Figures 3C and 3D).
At the 3S stage and thereafter, the CD34-sialomucins preferen-
tially localize to the luminal or apical plasma membranes (Figures
3E and 3F, and data not shown).
CD34-sialomucins are linked to the F-actin cytoskeleton via
Ezrin-Radixin-Moesin (ERM) adaptor proteins (reviewed by
Bretscher et al., 2002), known to be important for epithelial tubu-
logenesis (Gobel et al., 2004; Van Furden et al., 2004). Since the
ERM protein Moesin has been shown to be particularly abundant
in ECs (reviewed by Nielsen and McNagny, 2008), we asked
whether Moesin and F-actin colocalize with the CD34-sialomu-
cins at the onset of aortic lumen formation.
At the 1S stage, Moesin was mainly localized in the cytoplasm
(Figure 3G) and F-actin was localized along the entire EC surface
(Figure 3H). However, at the 2S stage, after the appearance ofDevelopCD34-sialomucins at the endothelial cell-cell contact (Figures 3C
and 3D), Moesin and F-actin were also enriched at the cell-cell
contact (Figures 3I and 3J). Consistent with its role as an adaptor
between CD34-sialomucins and F-actin, Moesin colocalized
with both PODXL and F-actin in ECs (data not shown). Subse-
quently, Moesin and F-actin localized at the luminal or apical
plasma membranes at the 3S stage and thereafter (Figures 3K
and 3L, and data not shown). In line with the notion that only
phosphorylated ERM proteins link CD34-sialomucins with
F-actin (reviewed by Bretscher et al., 2002), Moesin was found
to be phosphorylated at the luminal cell surface in ECs throughout
vascular lumen formation (Figures S2A, S2D, and S2G).
F-actin is known to interact with non-muscle (nm) Myosin II to
induce cell shape change in different cell types, including ECs
(Furman et al., 2007). At the 1S stage, nm-Myosin II was evenly
distributed within the cell (Figure 3M), but during the transition
from the 2S to the 3S stage, it became enriched at the endothelial
cell-cell contact and the luminal cell surface (Figures 3N and 3O).
At the same time, the ECs elongated and formed a vascular
lumen (Figures 3P–3R and Figures S3A–S3I).
These data show that CD34-sialomucins, Moesin, and F-actin
localize to the endothelial cell-cell contact, thus forming the
apical pole of vascular lumen formation. In addition, the datamental Cell 17, 505–515, October 20, 2009 ª2009 Elsevier Inc. 507
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Vascular Lumen Formation in the Developing AortaFigure 3. Localization of CD34-Sialomucins, Moesin, F-Actin, and nm-Myosin II at the Endothelial Cell-Cell Contact at the Onset of Vascular
Lumen Formation
Confocal images of (A–O) transverse and (P–R) sagittal sections through the developing dorsal aortae. Arrows point to the endothelial cell-cell contact. Asterisks
mark the developing lumen. En, endoderm; Mes, mesenchyme. 1S: cytoplasmic staining of (A) CD34, (B) Podocalyxin (PODXL), and (G) Moesin. (H) Weak
F-actin and (M) absent nm-Myosin II staining at the endothelial cell-cell contact. (P) Slightly oval-shaped EC. 2S: (C) CD34, (D) PODXL, (I) Moesin, (J) F-actin,
and (N) some nm-Myosin II localize at the endothelial cell-cell contact. (Q) Slightly oval-shaped EC. 3S: (E) CD34, (F) PODXL, (K) Moesin, (L) F-actin, and
(O) nm-Myosin II are enriched at the plasma membranes facing the developing vascular lumen (asterisks). (R) ECs are elongated. Scale bars, 5 mm (A–O) and
10 mm (P–R).suggest that interaction of nm-Myosin II with apically enriched F-
actin initiates the EC shape changes involved in vascular lumen
formation (Figures S4A and S4B).
Vascular Endothelial-Cadherin Is Required
for Localizing CD34-Sialomucins at the Endothelial
Cell-Cell Contact
Since EC polarization and vascular lumen formation was
observed once ECs had established a cell-cell contact, we
investigated the role of the EC-specific vascular endothelial
(VE)-cadherin in vascular lumen formation. Cadherins, a super-
family of calcium-dependent cell adhesion molecules, induce
cell polarity in epithelial cells (Nejsum and Nelson, 2007). There-
fore, we asked whether VE-Cadherin is also required for estab-
lishing cell polarity in ECs of the developing dorsal aortae.
At the 1S stage, no significant differences were observed in
the dorsal aortae between control embryos and VE-Cadherin-
deficient embryos (VE-Cadherin/; compare upper panels of
Figure 4 with upper panels of Figure 3). However, at the 3S stage,
CD34, PODXL, and Moesin were not enriched at the cell-cell
contact in VE-Cadherin-deficient ECs (compare Figures 3E, 3F,
and 3K with Figures 4C, 4D, and 4H). In addition, as previously
described (Carmeliet et al., 1999), VE-Cadherin-deficient ECs
failed to form a proper vascular lumen (Figures S3J–S3R).508 Developmental Cell 17, 505–515, October 20, 2009 ª2009 ElsePhospho-Moesin was also not enriched at the endothelial cell-
cell contact, but was more randomly located along the EC
surface (compare Figures S2A, S2D, and S2G with Figures
S2B, S2E, and S2H). Concordantly, in contrast to control
embryos, in VE-Cadherin-deficient embryos, F-actin was weak
and patchy at the endothelial cell-cell contact (compare Figures
3L and 4I), nm-Myosin II was absent from the apical or luminal
cell surface (compare Figures 3O and 4J), and ECs did not elon-
gate (compare Figures 3R and 4L).
The defects observed in early vascular lumen formation in VE-
Cadherin-deficient embryos were not due to a reduced number
of ECs or an increased rate of apoptosis (Figure S5). However, in
agreement with previous findings (Carmeliet et al., 1999), at
much later stages of development (14S), apoptotic cells were
observed (Figure S5). Our data, therefore, show that apoptosis
is not responsible for the alterations observed in VE-Cadherin-
deficient embryos at the 1–3S stage.
In the developing dorsal aortae, VE-Cadherin flanked the
PODXL-positive apical or luminal cell surface throughout the
initial steps of vascular lumen formation (Figure S6). Interestingly,
E-cadherin associates with the Phosphatase and Tensin homo-
log (PTEN) (Li et al., 2007; Vogelmann et al., 2005), which is
necessary and sufficient for establishing apical cell polarity and
lumen formation in MDCK epithelial cells (Martin-Belmontevier Inc.
Developmental Cell
Vascular Lumen Formation in the Developing AortaFigure 4. Impaired EC Polarization in VE-Cadherin-Deficient Mouse Embryos
Confocal images of (A–J) transverse and (K, L) sagittal sections through dorsal aortae in VE-Cadherin-deficient mouse embryos. Arrows point to the endothelial
cell-cell contact. En, endoderm; Mes, mesenchyme. 1S: cytoplasmic staining of (A) CD34, (B) Podocalyxin (PODXL), and (E) Moesin. (F) Weak F-actin and (G)
absent nm-Myosin II staining at the endothelial cell-cell contact. (K) Slightly oval-shaped EC. 3S: no enrichment of (C) CD34, (D) PODXL, (H) Moesin, (I) F-actin,
or (J) nm-Myosin II at the endothelial cell-cell contact. (L) No EC elongation. No difference was observed between the 2S and 3S stages. Scale bars, 5 mm (A–J)
and 10 mm (K, L).et al., 2007). To test whether PTEN plays a similar role in ECs, we
injected PTEN inhibitor bpV(pic) into the mesenchyme of mouse
embryos at the 1S stage, and subsequently allowed these
embryos to develop in whole embryo culture (WEC). WEC
proved useful for studying early vascular development, since
1–2S stage embryos with no lumenized blood vessels and no
heart (Figures 1A–1C) develop a functional circulatory system,
fully lumenized dorsal aortae, and a beating heart in WEC
(Figure S7 and data not shown). In addition, the dorsal aortae
in WEC mouse embryos developed spatially and temporally
similarly to mouse embryos in utero (Figure S7). Injection of
bpV(pic) partially phenocopied the VE-Cadherin deficiency
(Figure S8), since PODXL and Moesin were not enriched at the
endothelial cell-cell contact (compare Figures S8A and S8B
with Figures 4D and 4H), and a vascular lumen did not develop
(Figures S8C and S8D).
Taken together, these data show that VE-Cadherin, possibly
via PTEN, is required for establishing cell polarity in aortic ECs
(compare Figures S4B and S4C).
PODXL and Moesin Are Required for Early Vascular
Lumen Formation
Since VE-Cadherin was required for PODXL and Moesin locali-
zation at the endothelial cell-cell contact, we asked whether
these proteins are also functionally involved in aortic lumen
formation (Figure S9). We first analyzed mice deficient for PODXL
(Doyonnas et al., 2001) at the 3S stage, when a small lumen has
started to develop. Importantly, in the absence of PODXL, Moe-
sin was diffusively distributed in the cytoplasm (compare Figures
S9D and S9E), and F-actin was distributed along the entire
plasma membranes rather than enriched at the endothelialDevelopcell-cell contact (compare Figures S9G and S9H). In addition,
at the 6–8S stage, 40% of the PODXL-deficient dorsal aortae
had not yet formed a vascular tube, while the control dorsal
aortae had fully lumenized (Figure S9M, compare Control
with PODXL/). Finally, the diameter of the aortic lumen in
PODXL-deficient embryos was less than half that of the control
diameter (compare Figures S9J and S9K, and Figure S9N).
We next analyzed mice deficient for Moesin (Moesin/) (Doi
et al., 1999), and observed that PODXL was correctly positioned
at the endothelial cell-cell contact (Figure S9C). However,
consistent with its role as an adaptor between CD34-sialomu-
cins and F-actin, the F-actin was not enriched at the cell-cell
contact where PODXL was found (compare Figures S9G and
S9I). Finally, at the 6–8S stage, 20% of the Moesin-deficient
dorsal aortae had not formed a vascular tube (Figure S9M,
compare Control with Moesin/), and the diameter of the aortic
lumen was about half that of the control (compare Figures S9J
and S9L, and Figure S9N).
These data provide genetic evidence that PODXL and Moesin
play a role in recruiting F-actin to the apical EC surface and are
required for timely vascular lumen formation in the early dorsal
aortae.
Protein Kinase C Activity Is Required for Moesin
Phosphorylation
Only phosphorylated ERM proteins link CD34-sialomucins to the
F-actin cytoskeleton (for review see Bretscher et al. [2002]).
ERM protein phosphorylation is thought to involve the serine/
threonine protein kinase activities of either protein kinase C
(PKC) or Rho-associated protein kinase (ROCK) (Hebert et al.,
2008; Ng et al., 2001). Moreover, ROCK phosphorylates andmental Cell 17, 505–515, October 20, 2009 ª2009 Elsevier Inc. 509
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Vascular Lumen Formation in the Developing AortaFigure 5. Protein Kinase C and Rho-Associated Protein Kinase Have Different Roles in Aortic Lumen Formation
(A and B) Different effects of protein kinase C (PKC) inhibitor Ro 31-8220 and Rho-associated protein kinase (ROCK) inhibitor Y27632 on Moesin and Myosin light
chain (MLC) phosphorylation in human umbilical vein ECs (HUVECs). (A) Western blot of phospho (p)-Moesin and phospho (p)-MLC in HUVECs. (B) Quantification
of the relative p-Moesin (white bars) and p-MLC levels (black bars) after inhibiting PKC (Ro 31-8220) or ROCK (Y27632). Equal amounts of cells were used, and
phosphoproteins were normalized to b-actin (n = 3 experiments; *p < 0.001). All values are means ± SD.
(C–T) Effect of PKC and ROCK inhibitors on Podocalyxin (PODXL) localization, Moesin phosphorylation, F-actin and nm-Myosin II recruitment to the
endothelial cell-cell contact, and formation of an aortic lumen (asterisk) in ex vivo-cultured mouse embryos. (C–F, I–L, O–R) Confocal images of transverse
sections through dorsal aortae after whole-embryo culture (WEC) from the 2S to 2–3S stage for 30 min. (G, M, S) Confocal images of transverse sections
through dorsal aortae after WEC from the 2S to 7S stage for 5–7 hr. Embryos were injected with (C–H) PBS, (I–N) PKC inhibitor (Ro 31-8220), or (O–T)
ROCK inhibitor (Y27632). Sections were stained for the indicated markers, and arrows point to the endothelial cell-cell contact. En, endoderm; NE,
neuroepithelium. Scale bars, 5 mm (C–F, I–L, O–R) and 50 mm (G, M, S). (H, N, T) Quantification of cords and tubes after WEC from the 2S to 7S stage after
the treatment indicated on the left (n R 100 [control] or n R 200 aortic sections [treatment] of n R 3 embryos per condition; *p < 0.05). All values are
means ± SD.activates Myosin regulatory light chain (MLC), which is generally
required for actomyosin-based cell shape changes (reviewed
by Riento and Ridley, 2003). We therefore investigated whether
the kinase activities of PKC and ROCK are required for phos-
phorylation of Moesin and MLC in human umbilical vein ECs
(HUVECs).
We used Ro 31-8220 as a pan-PKC inhibitor to inhibit the
PKC isoforms identified in sorted aortic ECs (Figure S10),
and Y27632 as an inhibitor of ROCK I and II. We found that
inhibition of PKC prevented phosphorylation of Moesin, but
did not affect phosphorylation of MLC (Figures 5A and 5B,
compare PKC inhibitor with Control). Conversely, inhibition
of ROCK prevented phosphorylation of MLC, but did not
affect Moesin phosphorylation (Figures 5A and 5B, compare
ROCK inhibitor with Control). These specific effects of PKC510 Developmental Cell 17, 505–515, October 20, 2009 ª2009 Elsevon Moesin phosphorylation and of ROCK on MLC phosphor-
ylation were also confirmed with a different set of inhibitors
(Figure S11).
In order to further confirm these findings in the developing
mouse dorsal aortae, and to investigate whether PKC and
ROCK affect aortic lumen formation, we analyzed mouse
embryos injected with the respective inhibitors (Figures 5C–
5T). When the PKC inhibitor Ro 31-8220 was injected, PODXL
correctly localized to the endothelial cell-cell contact (compare
Figures 5C and 5I), but Moesin failed to be phosphorylated in
the aortic ECs (compare Figures 5D and 5J). Concomitantly,
F-actin and nm-Myosin II were not recruited to the endothelial
cell-cell contact (compare Figures 5E and 5F with Figures 5K
and 5L), and ECs failed to form vascular tubes (compare Figures
5G and 5H with Figures 5M and 5N).ier Inc.
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Vascular Lumen Formation in the Developing AortaFigure 6. Impaired Recruitment of nm-Myosin II to the Endothelial Cell-Cell Contact and Lack of EC Elongation in Vascular Endothelial
Growth Factor Haploinsufficient Mouse Embryos
(A–L) Confocal images of (A–J) transverse and (K, L) sagittal sections through developing dorsal aortae of vascular endothelial growth factor (VEGF)-A haplo-
insufficient mouse embryos. Arrows point to the endothelial cell-cell contact. En, endoderm; Mes, mesenchyme. 1S: cytoplasmic staining of (A) CD34, (B) Po-
docalyxin (PODXL), and (E) Moesin. (F) Weak F-actin and (I) absent nm-Myosin II staining at the endothelial cell-cell contact. (K) Slightly oval-shaped EC. 3S: (C)
CD34, (D) PODXL, (G) Moesin, and (H) F-actin, but not (J) nm-Myosin II, localize at the endothelial cell-cell contact. (L) No EC elongation. No difference was
observed between the 2S and 3S stages. Scale bars, 5 mm (A–J) and 10 mm (K, L).When the ROCK-inhibitor Y27632 was injected, PODXL local-
ized to the endothelial cell-cell contact (compare Figures 5C and
5O), Moesin phosphorylation was not inhibited (compare Figures
5D and 5P), and F-actin was appropriately recruited to the
endothelial cell-cell contact (compare Figures 5E and 5Q).
However, nm-Myosin II, which requires MLC phosphorylation
for its interaction with F-actin (reviewed by Riento and Ridley,
2003), failed to localize to the F-actin at the endothelial cell-cell
contact (compare Figures 5F and 5R), and the ECs formed
vascular tubes to a lesser extent (compare Figures 5G and 5H
with Figures 5S and 5T).
PKC activity is therefore required for Moesin phosphorylation
and F-actin recruitment to the endothelial cell-cell contact,
whereas ROCK activity is required for MLC phosphorylation
and nm-Myosin II recruitment to the apically enriched F-actin.
Vascular Endothelial Growth Factor-A Activates ROCK
and MLC, Enabling nm-Myosin II Recruitment to the
Endothelial Cell-Cell Contact and EC Shape Change
Vascular endothelial growth factor (VEGF)-A regulates ROCK
activity (Nacak et al., 2007; Sun et al., 2006), and is required
for embryonic blood vessel formation (Carmeliet et al., 1996; Fer-
rara et al., 1996). To investigate the role of VEGF-A in aortic
lumen formation, we crossed PGK-Cre mice, expressing Cre re-
combinase early and ubiquitously (Lallemand et al., 1998) with
VEGF-AloxP mice (Gerber et al., 1999) to obtain haploinsufficient
VEGF-A+/ mouse embryos (Figure 6). These embryos com-
pletely failed to form lumenized dorsal aortae (Figures S3S–
S3AA) despite the surprisingly normal polarization of the aortic
ECs (i.e., CD34, PODXL, Moesin, and F-actin were recruited to
the endothelial cell-cell contact [Figures 6C, 6D, 6G, and 6H]).DevelopMoesin was also normally phosphorylated (Figures S2C, S2F,
and S2I). Nm-Myosin II, however, was completely absent from
the endothelial cell-cell contact (Figure 6J), and the ECs did
not elongate in VEGF-A haploinsufficient mouse embryos (Fig-
ures 6K and 6L). Importantly, these early defects in aortic lumen
formation were not attributable to either a reduced EC number or
an increased apoptosis rate (Figure S5).
Because both VEGF-A and ROCK were found to be required
for the recruitment of nm-Myosin II to the apical cell surface at
the endothelial cell-cell contact, we asked whether VEGF-A is
upstream of ROCK (Figures S12A–S12D). Accordingly, we stim-
ulated HUVECs with VEGF-A, and analyzed the activity of ROCK
and its downstream signal MLC. Our data show that VEGF-A
significantly increased ROCK activity (Figures S12A and S12B)
and activated MLC, as measured by MLC phosphorylation
(Figures S12C and S12D). Moreover, VEGF-A signaling was
required for MLC activation, as application of the VEGF-A
signaling inhibitors, Flt1-Fc and SU5416, significantly decreased
MLC phosphorylation in HUVECs (Figures S12C and S12D).
We next inhibited VEGF-A signaling in WEC using these two
pharmacological inhibitors (Figures S12E–S12S). Importantly,
the VEGF-A signaling inhibitors reproduced the effects observed
in VEGF-A haploinsufficient (VEGF-A+/) mouse embryos (Fig-
ures S12E–S12S). In particular, when SU5416 was used at a
concentration 403 higher than that to fully block VEGF receptor
signaling in HUVECs (Mendel et al., 2000), EC polarity was prop-
erly established (i.e., both PODXL and Moesin were enriched at
the endothelial cell-cell contact, and Moesin was phosphory-
lated [Figures S12O and S12P]). In contrast, nm-Myosin II was
not recruited to the apical cell surface (compare Figures S12G
and S12Q), and the ECs did not form vascular tubes (comparemental Cell 17, 505–515, October 20, 2009 ª2009 Elsevier Inc. 511
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(A) Adjacent ECs adhere to each other via junctions at multiple positions along the endothelial cell-cell contact.
(B) VE-Cadherin is required for localizing of CD34-sialomucins to the endothelial cell-cell contact, possibly via its interaction with Phosphatase and Tensin
homolog. The antiadhesive CD34-sialomucins are involved in separating apical EC surfaces from each other.
(C) PKC activity is required for phosphorylating Moesin, which is involved in recruiting F-actin to the apical cell surface at the endothelial cell-cell contact.
(D) VEGF-A activates ROCK, which is required for MLC phosphorylation and recruitment of nm-Myosin II to the apically enriched F-actin. VEGF-A and ROCK are
required for fully separating apicalECsurfaces from eachother, for EC shape changes,and for vascular lumen formation. In invitro vascular tubes, theF-actin isoriented
parallel to the longitudinal axis of the vascular lumen (data not shown), suggesting a similar F-actin orientation in the developing aorta. Since the developing lumen
(asterisk) is leaky, extravascular interstitial fluid (gray dots) passively enters via paracellular openings.Figures S12H and S12I with Figures S12R and S12S). The only
lumenized dorsal aortae were observed cranially and caudally,
far away from the injection sites (data not shown).
Combined, our data strongly suggest that VEGF-A signaling is
not required for EC polarization and Moesin phosphorylation, but
is specifically required for recruitment of nm-Myosin II to the
endothelial cell-cell contact, EC shape change, and aortic lumen
formation (compare Figures S4B and S4D).
DISCUSSION
The circulatory system is the first functional organ system to
develop in vertebrates. Its proper function strictly depends on lu-
menized blood vessels to execute vital tasks, such as the trans-
port of blood cells, nutrients, gases, and wastes to and from all
organs and tissues. During blood vessel formation, ECs are the
only cell type capable of forming lumenized vascular tubes.
The first study on in vivo vascular lumen formation in zebrafish
suggested that large intracellular vacuoles developed in ECs
and remained there for several hours before coalescing with
the vacuoles from adjacent ECs (Kamei et al., 2006). However,
recently, another study on the same blood vessels in zebrafish
suggested that the vascular lumen did not develop via vacuole
coalescence, but instead developed extracellularly between
adjacent ECs (Blum et al., 2008). Neither study suggested a
molecular mechanism of vascular lumen formation, or explained
the role of key factors, such as VE-Cadherin or VEGF-A, in their
particular models.512 Developmental Cell 17, 505–515, October 20, 2009 ª2009 ElsevFormation of an Apical Cell Surface at the Endothelial
Cell-Cell Contact
Here, we performed a detailed structure/function analysis of the
developing aorta to propose a molecular mechanism of in vivo
vascular lumen formation (Figure 7; Movie S2). Interestingly,
similar to lumen formation in blood vessels of other systems
(Blum et al., 2008; Jin et al., 2005; Kamei et al., 2006), we
observed in the developing mouse dorsal aortae that ECs first
assemble in the form of an EC cord (Figure 7A) before developing
a central vascular lumen. The first step in lumen formation is thus
the adhesion of ECs to each other (Figure 7A). After junctional re-
localization, an apical pole interface develops between adjacent
ECs (Figure 7B, green color) flanked by VE-Cadherin-expressing
junctions (Figure 7B, gray rectangles). The vascular lumen thus
develops at the cell-cell contact between adjacent ECs
(Figure 7B).
VE-Cadherin is required to form these apical cell surfaces at
the endothelial cell-cell contact (Figure 7B, green color). Since
we found that the apical glycoproteins, CD34 and PODXL, are
located in vesicles (Figure 7A, green circles), and that PTEN is
required for EC polarization, it is possible that VE-Cadherin facil-
itates exocytosis of apical glycoproteins at the endothelial cell-
cell contact via an interaction with PTEN.
Role of CD34-Sialomucins at the Luminal Cell Surface
of ECs
Once CD34-sialomucins cover the apical cell surface (Figure 7B,
green rectangles), ECs de-adhere from each other and give riseier Inc.
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color). Interestingly, cell-cell repulsion as a mechanism of lumen
formation has been recently described for heart formation in
Drosophila (Medioni et al., 2008; Santiago-Martinez et al., 2008),
and the apical cell surface glycoproteins, CD34 and PODXL,
have been shown to be antiadhesive due to their negatively
charged glycosyl residues (reviewed by Nielsen and McNagny,
2008). Importantly, deletion of PODXL was sufficient to signifi-
cantly delay aortic lumen formation in mouse embryos, showing
that apical antiadhesive glycoproteins play a functional role in
generating an extracellular vascular lumen at the endothelial
cell-cell contact (Figure 7B, green rectangles).
Recruitment of F-Actin to the Luminal Cell Surface
CD34-sialomucins connect with the F-actin cytoskeleton via
functionally redundant ERM proteins (reviewed by Bretscher
et al. [2002]). Moesin appears to be the most abundant ERM
protein in mammalian ECs (Koss et al., 2006; Okada et al.,
2005) (yellow ovals in Figures 7B and 7C), and we found that
deletion of Moesin in mice delays aortic lumen formation and
decreases the amount of apical F-actin in early aortic ECs. In
addition, loss of PODXL reduces the amount of Moesin and
F-actin located at the endothelial cell-cell contact, suggesting
that PODXL connects with Moesin in order to recruit F-actin
and facilitate vascular lumen formation (Figures 7B–7C).
Moesin must be phosphorylated in order to link CD34-sialo-
mucins with the F-actin cytoskeleton (reviewed by Bretscher
et al. [2002]). Here, we show that PKC, but not ROCK, is required
for Moesin phosphorylation in aortic ECs (Figures 7B–7C). Inter-
estingly, aortic ECs express several novel PKC (nPKC) and atyp-
ical PKC (aPKC) isoforms during aortic lumen formation, and
microarrays of HUVECs, cultured in monolayers and lumenized
sprouts, showed that nPKC-theta, along with nPKC-eta, is upre-
gulated upon in vitro vascular lumen formation (data not shown).
Thus, a PKC-dependent step leads to the phosphorylation of
Moesin (Figures 7B–7C), which directly or indirectly links the
F-actin cytoskeleton (Figure 7C, red lines) to the apical CD34-
sialomucins in aortic ECs.
VEGF-A-Dependent EC Shape Change
We show that VEGF-A increases ROCK activity (Figures 7C and
7D), and that this is required for activating MLC and recruiting
nm-Myosin II (Figure 7D, green bars) to the apical EC surface.
These observations suggest that VEGF-A induces the formation
of an actomyosin complex at the apical cell surface to promote
endothelial cell-cell separation, leading to vascular lumen forma-
tion (Figures 7C and 7D). Since the developing vascular lumen is
leaky, interstitial fluid should be able to passively enter the lumen
via paracellular openings (Figure 7D, gray dots).
AMolecularModel for In Vivo Vascular LumenFormation
Our study on the developing aorta has yielded a molecular
mechanism by which a vascular lumen forms in vivo (Figure 7,
Movie S2). In addition, localization of CD34, PODXL, and Moesin
at the endothelial cell-cell contact was also found during blood
vessel formation in the developing lung and kidney, as well as
in Lewis lung carcinoma (Figure S13). It is thus likely that many
aspects of the proposed molecular mechanism are applicable
to vascular lumen formation in other developing blood vessels.DevelopEXPERIMENTAL PROCEDURES
Mouse Strains
NMRI or C57BL/6 mice (Harlan Laboratories, Horst, The Netherlands) were
used for wild-type studies and WEC. PODXL/ (Doyonnas et al., 2001),
Moesin/ (Doi et al., 1999), VE-Cadherin/ (Carmeliet et al., 1999), VEGF-
AloxP (Gerber et al., 1999), and PGK-Cre mice (Lallemand et al., 1998) have
previously been described. Littermates or mouse embryos of similar genetic
background were used as controls.
Mouse Embryo Isolation
Isolated mouse embryos were sorted by number of somites. After isolation or
WEC, all embryos were fixed in either 4% paraformaldehyde (PFA) in PBS,
2.5% glutaraldehyde with 2% PFA in 0.1 M Na-cacodylate buffer, or 5%
trichloroacetic acid in PBS, and further processed for imaging.
Embryonic Injections and Whole-Embryo Culture
All embryos were isolated, dissected, and kept in PBS (+Mg2+, +Ca2+) at 37C
during injection. For WEC, all substances were injected in an aqueous solution
containing phenol red diluted 1:10 in PBS in order to monitor their localization.
200 mM Ro 31-8220 (Biaffin), 200 mM Y27632 (Calbiochem), 500 ng/ml Flt1-Fc
(R&D Systems), 200 mM SU5416 (Sigma), or 200 mM bpV(pic) (Merck Biosci-
ences) was injected into embryos at the 1S or 2S stage from the ventral
side through the endoderm into the mesenchyme. PBS alone, 1% DMSO, or
500 ng/ml IgG1-Fc (R&D Systems) served as controls. After injection, embryos
were transferred into rat serum (Charles River Laboratories) containing 1%
HEPES, and were roller-cultured (WEC) at 37C with 5% O2 for the indicated
times. After WEC, embryos were processed for immunostaining and imaging.
Immunostaining and Imaging
For confocal light microscopy, fixed embryos were cryopreserved in 30%
sucrose (Sigma), embedded in OCT (Fisher Scientific), and cryosectioned at
12 mm for transverse and 40 mm for sagittal sections, or kept intact for
whole-mount staining for SPIM. The following antibodies were used: rabbit
anti-Caspase3 (active) (Sigma), rat anti-CD34 (eBioscience), rabbit anti-Moe-
sin (Abcam), rabbit anti-nm-Myosin II heavy chain A (Covance Research),
rabbit anti-phospho-Moesin (Santa Cruz Biotechnology), rat anti-PECAM-1
(BD Bioscience), goat anti-PODXL (R&D Systems), and rat anti-VE-Cadherin
(Millipore). DAPI (Sigma) was used to stain cell nuclei, and Alexa Fluor (AF)
488-conjugated phalloidin (Molecular Probes) to stain F-actin. Secondary anti-
bodies were conjugated with AF488 or AF633 (Molecular Probes) and Cy3 or
Cy5 (Jackson ImmunoResearch). Images were acquired and analyzed using
a Zeiss 510 LSM or a Zeiss SPIM prototype. For the analysis of aortic lumens
in mouse embryos, transverse sections through the entire embryo were
analyzed. Projections and movies were generated using LSM 510 software
(Zeiss) or ImageJ (NIH), respectively. To identify ECs, all sections were co-
stained with either PECAM-1 or CD34. Preparation of samples for EM was
described previously (Kucera et al., 2009).
In Vitro Studies
HUVECs (Lonza) of passages < P8 were used for all experiments. Cells were
grown in EGM2 medium (Lonza) and incubated at 37C and 5% CO2. For
inhibition studies of PKC and ROCK, HUVECs were grown to confluence and
incubated with EGM2 containing 5 mM Ro 31-8220 (Biaffin), 5 mM Y27632
(Calbiochem), 1 mM Go¨6983 (Merck Biosciences), or 1 mM H-1152 (Merck
Biosciences) for 30 min. For studies addressing activation by VEGF-A or inhi-
bition of VEGF-A signaling, HUVECs were grown to 90% confluence and
starved for 6 hr in starvation medium (EGM2 + 0.5% FCS). Subsequently, cells
were incubated with starvation medium alone or supplemented with 2.5 mg/ml
Flt1-Fc or 5 mM SU5416 for 30 min, followed by stimulation with 10 ng/ml
VEGF-A165 (Biomol) for 10 min alone or with 2.5 mg/ml Flt1-Fc or 5 mM
SU5416. For the measurement of ROCK activity (Cell Biolabs, Inc.), cells
were starved for 6 hr and subsequently stimulated with 10 ng/ml VEGF-A165
for 10 min. Starvation medium alone, 1% DMSO, or 2.5 mg/ml IgG1-Fc served
as controls. For immunoblotting, rabbit anti-phospho-MLC (Cell Signaling),
rabbit anti-phospho-Moesin (Abcam), and mouse anti-b-actin (Sigma) anti-
bodies were used in combination with HRP-conjugated secondary antibodies
(Dianova). Equal amounts of cells were used, and phosphoproteins weremental Cell 17, 505–515, October 20, 2009 ª2009 Elsevier Inc. 513
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ImageJ (NIH).
PKC Expression Analysis in Aortic ECs
Embryos (1-6S) were isolated, freed from the yolk sac, cardiogenic plate, and
amnion, and incubated in dissociation solution (2.5 mg/ml collagenase IV,
10 mg/ml dispase II, 0.12 mg/ml DNase in HBSS) for 2 hr at 37C with slow
agitation. Cell suspensions were incubated with anti-PECAM-1 primary anti-
body (BD Bioscience) and AF488-conjugated secondary antibody (Molecular
Probes), FAC sorted for PECAM-1-positive ECs (i.e, dorsal aorta) and PECAM-
1-negative cells (i.e., embryo), followed by cDNA synthesis and PCR (for a list
of primers, see Table S1). A mixture of tissues from an adult mouse served as
a positive control.
Statistical Analysis
Data are presented as means ± SD or ± SEM (see figure legends). Student’s t
tests were used for statistical analysis; p < 0.05 was considered statistically
significant.
SUPPLEMENTAL DATA
Supplemental Data include thirteen figures, one table, and two movies and can
be found with this article online at http://www.cell.com/developmental-cell/
supplemental/S1534-5807(09)00349-9/.
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